Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Sep 7, 2016Rodman & Renshaw 18th Annual Global Investment Conference - News
CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to prevent or treat deadly inflammation and organ failure in...
-
Sep 7, 2016Virtual Press Office and PR Newswire: General Trade show news
Asterias Biotherapeutics, Inc. (NYSE MKT: AST), today announced that Edward Wirth, MD, PhD, Chief Medical Officer, will present interim efficacy data from the 10 million cell cohort in the...
-
Sep 7, 2016Rodman & Renshaw 17th Annual Global Investment Conference - News
Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual...
-
Sep 7, 2016Virtual Press Office and PR Newswire: General Trade show news
Bruker today unveils two new preclinical imaging systems at the World Molecular Imaging Congress 2016 (WMIC: http://www.wmis.org) in New York. The new systems are designed to deliver highest...
-
Sep 7, 2016Virtual Press Office and PR Newswire: General Trade show news
Gerald L. Hassell, chairman and chief executive officer of BNY Mellon, and Thomas P. Gibbons, vice chairman and chief financial officer of BNY Mellon, will be presenting at the 2016 Barclays...
-
Sep 7, 2016Virtual Press Office and PR Newswire: General Trade show news
Powering Precision Health 2016, the nation's first biomed innovation-driven summit, today announced its unprecedented keynote lineup of industry icons. Founded by life sciences visionary and...
-
Sep 7, 2016Virtual Press Office and PR Newswire: General Trade show news
VolitionRx Limited (NYSE MKT: VNRX), a life sciences company focused on developing diagnostic tests for cancer, today announced that its Chief Executive Officer, Cameron Reynolds, and its Vice...
-
Sep 7, 2016Rodman & Renshaw 18th Annual Global Investment Conference - News
VolitionRx Limited (NYSE MKT: VNRX), a life sciences company focused on developing diagnostic tests for cancer, today announced that its Chief Executive Officer, Cameron Reynolds, and its Vice...
-
Sep 7, 2016Virtual Press Office and PR Newswire: General Trade show news
Forge Therapeutics, Inc., announced presentations on its lead program targeting LpxC with novel chemistry to combat Gram-negative 'superbugs'. Presentations details are as follows: World...
-
Sep 7, 2016IBC 2016 Exhibitor news releases, online press kits
Evergent Technologies and Cisco announced their alignment to accelerate delivery and monetization of OTT video services for operators and broadcasters. The collaboration brings together the...